VF
PPH icon

Virtu Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Virtu Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-34,244
Closed -$2.02M – 2041
2018
Q2 		$2.02M Buy
34,244
+24,614
+256% +$1.43M 0.12% 162
2018
Q1 		$546K Buy
9,630
+5,631
+141% +$336K 0.03% 660
2017
Q4 		$237K Buy
3,999
+461
+13% +$26.4K 0.01% 1496
2017
Q3 		$204K Sell
3,538
-10,072
-74% -$572K 0.01% 1835
2017
Q2 		$804K Buy
+13,610
New +$770K 0.11% 167
2016
Q4 		– Sell
-40,385
Closed -$2.32M – 535
2016
Q3 		$2.32M Buy
+40,385
New +$2.42M 0.4% 53
2016
Q2 		– Sell
-75,736
Closed -$4.35M – 488
2016
Q1 		$4.35M Buy
+75,736
New +$4.48M 0.61% 35
2015
Q4 		– Sell
-35,076
Closed -$2.21M – 415
2015
Q3 		$2.21M Buy
+35,076
New +$2.47M 0.29% 81
2015
Q2 		– Sell
-11,297
Closed -$794K – 378
2015
Q1 		$794K Sell
11,297
-4,877
-30% -$331K 0.09% 144
2014
Q4 		$1.04M Buy
+16,174
New +$1.03M 0.13% 126
2014
Q2 		– Sell
-25,629
Closed -$1.5M – 427
2014
Q1 		$1.5M Buy
25,629
+5,739
+29% +$325K 0.21% 97
2013
Q4 		$1.06M Buy
19,890
+582
+3% +$29.5K 0.11% 138
2013
Q3 		$924K Sell
19,308
-34,621
-64% -$1.64M 0.09% 132
2013
Q2 		$2.45M Buy
+53,929
New +$2.49M 0.24% 79

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's PPH Position: Q3 2018 in Review

Virtu Financial sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2018, closing a stake of 34,244 shares — an estimated $2.02M sold.

Virtu Financial first reported a position in PPH in Q2 2013 and held it in 14 quarters. The position peaked at $4.35M in Q1 2016. 44 funds tracked by Wall St. Rank hold PPH as of Q3 2018.

  • Virtu Financial reported no remaining VanEck Pharmaceutical ETF position as of Q3 2018 after selling out during the quarter.
  • Virtu Financial sold 34,244 VanEck Pharmaceutical ETF shares in Q3 2018, an estimated $2.02M.
  • Virtu Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 14 quarters.
  • Virtu Financial's VanEck Pharmaceutical ETF position peaked at $4.35M in Q1 2016.
  • 44 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2018.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.